Female ‘viagra’ raises safety concerns

Published



The first-ever female libido drug might not mix well with alcohol or other medications, a new report suggests.

Advisers to the Food and Drug Administration will meet Thursday to weigh safety concerns with flibanserin, a pill that, if approved, would be the first drug to treat low female sexual interest and arousal.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.